| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 2 | -315,700 | 100% | $3.17 | -$1,000,580 |
| Net | -2 | -315,700 | -100% | -$1,000,580 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Leslie W. Kreis | 10%+ Owner | $3,344,781 | -$500,290 | -13% | 13 Jun 2025 |
| Aaron G.l. Fletcher | 10%+ Owner | $3,344,781 | -$500,290 | -13% | 13 Jun 2025 |
| Lee T. Schalop | Director | 09 Jan 2026 | |||
| Maria-Luisa Maccecchini | Director | 09 Jan 2026 | |||
| David S. Silberstein | Director | 09 Jan 2026 | |||
| Panna Sharma | President & CEO, Director | 19 Sep 2025 | |||
| Vijay Chandru | Director | 09 Jan 2026 | |||
| David R. Margrave | Chief Financial Officer | 18 Dec 2025 | |||
| Franklyn G. Prendergast | Director | 04 Nov 2021 | |||
| Kishor G. Bhatia | Chief Scientific Officer | 18 Dec 2025 | |||
| D. Jeffrey Keyser | Director | 09 Jan 2026 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| D. Jeffrey Keyser | LTRN | Stock Option (Right to Buy) | Award | 53,844 | 28,844 | 09 Jan 2026 | Direct | |||
| Maria-Luisa Maccecchini | LTRN | Stock Option (Right to Buy) | Award | 46,152 | 25,000 | 09 Jan 2026 | Direct | |||
| Vijay Chandru | LTRN | Stock Option (Right to Buy) | Award | 42,307 | 25,000 | 09 Jan 2026 | Direct | |||
| Lee T. Schalop | LTRN | Stock Option (Right to Buy) | Award | 43,460 | 25,000 | 09 Jan 2026 | Direct | |||
| David S. Silberstein | LTRN | Stock Option (Right to Buy) | Award | 42,307 | 25,000 | 09 Jan 2026 | Direct | |||
| David R. Margrave | LTRN | Stock Option (Right to Buy) | Award | 20,000 | 20,000 | 18 Dec 2025 | Direct | |||
| Kishor G. Bhatia | LTRN | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 18 Dec 2025 | Direct | |||
| Lee T. Schalop | LTRN | Stock Option (Right to Buy) | Award | 5,000 | 5,000 | 19 Aug 2025 | Direct | |||
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -3.67% | $13,454 | $3.09 | -4,354 | 114,272 | 13 Jun 2025 | by Bios Fund II, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -3.67% | $43,934 | $3.09 | -14,218 | 373,178 | 13 Jun 2025 | By Bios Fund II QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -3.67% | $5,880 | $3.09 | -1,903 | 49,957 | 13 Jun 2025 | By Bios Fund II NT, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -3.67% | $38,066 | $3.09 | -12,319 | 323,335 | 13 Jun 2025 | By Bios Fund I, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -3.67% | $22,267 | $3.09 | -7,206 | 189,117 | 13 Jun 2025 | By Bios Fund I QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -3.67% | $13,454 | $3.09 | -4,354 | 114,272 | 13 Jun 2025 | By Bios Fund II, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -3.67% | $43,934 | $3.09 | -14,218 | 373,178 | 13 Jun 2025 | By Bios Fund II QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -3.67% | $5,880 | $3.09 | -1,903 | 49,957 | 13 Jun 2025 | By Bios Fund II NT, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -3.67% | $38,066 | $3.09 | -12,319 | 323,335 | 13 Jun 2025 | By Bios Fund I, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -3.67% | $22,267 | $3.09 | -7,206 | 189,117 | 13 Jun 2025 | By Bios Fund I QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -5.27% | $22,311 | $3.38 | -6,601 | 118,626 | 12 Jun 2025 | By Bios Fund II, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -5.27% | $72,863 | $3.38 | -21,557 | 387,396 | 12 Jun 2025 | By Bios Fund II QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -5.27% | $9,755 | $3.38 | -2,886 | 51,860 | 12 Jun 2025 | By Bios Fund II NT, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -5.27% | $63,132 | $3.38 | -18,678 | 335,654 | 12 Jun 2025 | By Bios Fund I, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -5.27% | $36,926 | $3.38 | -10,925 | 196,323 | 12 Jun 2025 | By Bios Fund I QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -5.27% | $22,311 | $3.38 | -6,601 | 118,626 | 12 Jun 2025 | By Bios Fund II, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -5.27% | $72,863 | $3.38 | -21,557 | 387,396 | 12 Jun 2025 | By Bios Fund II QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -5.27% | $9,755 | $3.38 | -2,886 | 51,860 | 12 Jun 2025 | By Bios Fund II NT, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -5.27% | $63,132 | $3.38 | -18,678 | 335,654 | 12 Jun 2025 | By Bios Fund I, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -5.27% | $36,926 | $3.38 | -10,925 | 196,323 | 12 Jun 2025 | By Bios Fund I QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -0.08% | $350 | $3.40 | -103 | 125,227 | 11 Jun 2025 | By Bios Fund II, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -0.08% | $1,149 | $3.40 | -338 | 408,953 | 11 Jun 2025 | By Bios Fund II QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -0.08% | $153 | $3.40 | -45 | 54,746 | 11 Jun 2025 | By Bios Fund II NT, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -0.08% | $996 | $3.40 | -293 | 354,332 | 11 Jun 2025 | By Bios Fund I, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -0.08% | $581 | $3.40 | -171 | 207,248 | 11 Jun 2025 | By Bios Fund I QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -0.08% | $350 | $3.40 | -103 | 125,227 | 11 Jun 2025 | By Bios Fund II, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -0.08% | $1,149 | $3.40 | -338 | 408,953 | 11 Jun 2025 | By Bios Fund II QP, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -0.08% | $153 | $3.40 | -45 | 54,746 | 11 Jun 2025 | By Bios Fund II NT, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -0.08% | $996 | $3.40 | -293 | 354,332 | 11 Jun 2025 | By Bios Fund I, LP |
| Leslie W. Kreis | LTRN | Common Stock | Sale | -0.08% | $581 | $3.40 | -171 | 207,248 | 11 Jun 2025 | By Bios Fund I QP, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | $6.8 | $3.40 | -2 | 125,330 | 10 Jun 2025 | By Bios Fund II, LP | |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | $17 | $3.40 | -5 | 409,291 | 10 Jun 2025 | By Bios Fund II QP, LP | |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | $3.4 | $3.40 | -1 | 54,791 | 10 Jun 2025 | By Bios Fund II NT, LP | |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | $17 | $3.40 | -5 | 354,625 | 10 Jun 2025 | By Bios Fund I, LP | |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | $10.2 | $3.40 | -3 | 207,419 | 10 Jun 2025 | By Bios Fund I QP, LP | |
| Leslie W. Kreis | LTRN | Common Stock | Sale | $6.8 | $3.40 | -2 | 125,330 | 10 Jun 2025 | By Bios Fund II, LP | |
| Leslie W. Kreis | LTRN | Common Stock | Sale | $17 | $3.40 | -5 | 409,291 | 10 Jun 2025 | By Bios Fund II QP, LP | |
| Leslie W. Kreis | LTRN | Common Stock | Sale | $3.4 | $3.40 | -1 | 54,791 | 10 Jun 2025 | By Bios Fund II NT, LP | |
| Leslie W. Kreis | LTRN | Common Stock | Sale | $17 | $3.40 | -5 | 354,625 | 10 Jun 2025 | By Bios Fund I, LP | |
| Leslie W. Kreis | LTRN | Common Stock | Sale | $10.2 | $3.40 | -3 | 207,419 | 10 Jun 2025 | By Bios Fund I QP, LP | |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -1.72% | $6,663 | $3.03 | -2,199 | 125,332 | 29 May 2025 | By Bios Fund II, LP |
| Aaron G.l. Fletcher | LTRN | Common Stock | Sale | -1.72% | $21,755 | $3.03 | -7,180 | 409,296 | 29 May 2025 | By Bios Fund II QP, LP |